[
  {
    "ts": null,
    "headline": "OPK Stock Gains Following Q3 Earnings Beat, Gross Margin Contracts",
    "summary": "Lower revenues from OPKO Health's products and services dampen its overall third-quarter 2024 performance.",
    "url": "https://finnhub.io/api/news?id=17d4e14c60b2b0ad904351002815a66dd61c4434c0692656f9de4f34eb8b52ee",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731086040,
      "headline": "OPK Stock Gains Following Q3 Earnings Beat, Gross Margin Contracts",
      "id": 131228257,
      "image": "https://media.zenfs.com/en/zacks.com/720c8da91f84eaf3696b8496766072f1",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Lower revenues from OPKO Health's products and services dampen its overall third-quarter 2024 performance.",
      "url": "https://finnhub.io/api/news?id=17d4e14c60b2b0ad904351002815a66dd61c4434c0692656f9de4f34eb8b52ee"
    }
  },
  {
    "ts": null,
    "headline": "AMN Stock Falls Despite Q3 Earnings & Revenues Beat, Margins Contract",
    "summary": "AMN Healthcare's dismal results in the majority of its segments led to a soft overall third-quarter performance.",
    "url": "https://finnhub.io/api/news?id=983d9c2cfe68dc892e791a3bd7f76b34b2bc6d9589aad304e5b99cbddb631461",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731085920,
      "headline": "AMN Stock Falls Despite Q3 Earnings & Revenues Beat, Margins Contract",
      "id": 131228258,
      "image": "https://media.zenfs.com/en/zacks.com/ebb8b8a767e89fdab119b9ddef47f7b2",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "AMN Healthcare's dismal results in the majority of its segments led to a soft overall third-quarter performance.",
      "url": "https://finnhub.io/api/news?id=983d9c2cfe68dc892e791a3bd7f76b34b2bc6d9589aad304e5b99cbddb631461"
    }
  },
  {
    "ts": null,
    "headline": "PBH Q2 Earnings Match Estimates, Revenues Beat, Shares Rise",
    "summary": "Prestige Consumer Healthcare's second-quarter sales are impacted by the ongoing supply chain challenges in the Clear Eyes business.",
    "url": "https://finnhub.io/api/news?id=c61e7a8182a57d519ae162928090482ba70c84f15383b7d8a75acbebdece2737",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731077940,
      "headline": "PBH Q2 Earnings Match Estimates, Revenues Beat, Shares Rise",
      "id": 131224059,
      "image": "https://media.zenfs.com/en/zacks.com/0ebf144352a95b22dfed01b36b0e82c5",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Prestige Consumer Healthcare's second-quarter sales are impacted by the ongoing supply chain challenges in the Clear Eyes business.",
      "url": "https://finnhub.io/api/news?id=c61e7a8182a57d519ae162928090482ba70c84f15383b7d8a75acbebdece2737"
    }
  },
  {
    "ts": null,
    "headline": "We Think Boston Scientific's (NYSE:BSX) Profit Is Only A Baseline For What They Can Achieve",
    "summary": "Even though Boston Scientific Corporation's ( NYSE:BSX ) recent earnings release was robust, the market didn't seem to...",
    "url": "https://finnhub.io/api/news?id=76b1e56ec105649a76c0a9cba5307a88e2f14817efd212f3d2eccd263c6322d3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731066333,
      "headline": "We Think Boston Scientific's (NYSE:BSX) Profit Is Only A Baseline For What They Can Achieve",
      "id": 131221504,
      "image": "https://media.zenfs.com/en/simply_wall_st__316/983f2bdfe32b19227b1d118c45bf4f09",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Even though Boston Scientific Corporation's ( NYSE:BSX ) recent earnings release was robust, the market didn't seem to...",
      "url": "https://finnhub.io/api/news?id=76b1e56ec105649a76c0a9cba5307a88e2f14817efd212f3d2eccd263c6322d3"
    }
  }
]